Top View
- WHO Pharmaceuticals
- Application of Mice Humanized for CYP2D6 to the Study of Tamoxifen Metabolism and Drug–Drug Interaction with Antidepressants S
- Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer S
- Product Monograph
- An Update of the Occurrence of Organic Contaminants of Emerging Concern in the Canary Islands (Spain)
- New Zealand Data Sheet Tamoxifen Sandoz (Tamoxifen Citrate) Film-Coated Tablets 1
- Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study Peter Fox1, Rosemary L
- Serum Concentrations of Active Tamoxifen Metabolites Predict Long
- The Pennsylvania State University
- ENDOXIFEN PHASE 2 STUDY FINAL DATA June 9, 2021
- Tamoxifen Or Raloxifene in Postmenopausal Women for Prevention of Breast Cancer: a Tale of Two Choices—Counterpoint
- TAG Mail: July – December 2020
- Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites
- Estrogen Receptor/ERR
- Managing Menopausal Symptoms and Associated Clinical Issues in Breast Cancer Survivors
- Molecular Mechanism for Breast Cancer Incidence in the Women's Health Initiative
- Profound Reduction in Tamoxifen Active Metabolite Endoxifen in a Breast
- Oral Low Dose and Topical Tamoxifen for Breast Cancer Prevention: Modern Approaches for an Old Drug
- The Effect Analysis of CYP2D6 Gene Polymorphism in the Toremifene and Tamoxifen Treatment in Patient with Breast Cancer
- Sulfation of Afimoxifene, Endoxifen, Raloxifene, and Fulvestrant by the Human Cytosolic Sulfotransferases
- Selective Estrogen Receptor Modulators Limit Alphavirus Infection by Targeting the Viral
- Understanding Aromatase: a Mechanistic Basis For
- Effect of Exemestane on Tamoxifen Pharmacokinetics in Postmenopausal Women Treated for Breast Cancer Paul R
- Atossa Genetics Completes All Dosing and Clinical Visits in Its Phase 1 Study of Topical Endoxifen in Men
- Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms
- Design, Synthesis and Biochemical Evaluation of Novel Selective Estrogen Receptor Ligand Conjugates Incorporating an Endoxifen-Combretastatin Hybrid Scaffold
- Atossa Genetics Pipeline Advancement
- Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring - the TADE Study
- 1 Rapid Induction of the Unfolded Protein Response and Apoptosis By
- Pharmacogenomic–Pharmacokinetic Study of Selective Estrogen-Receptor
- Download Disposition of Comments
- The Effects of a Novel Hormonal Breast Cancer Therapy, Endoxifen, on the Mouse Skeleton
- ( 12 ) United States Patent
- Gungor Serms Final Accepted
- Selective Estrogen Receptor Modulators and Phytoestrogens
- Summary of Product Characteristics
- Estrogen Sulfotransferase (SULT1E1): Its Molecular Regulation, Polymorphisms, and Clinical Perspectives